Corrigendum: Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis

Front Immunol. 2022 May 4:13:909105. doi: 10.3389/fimmu.2022.909105. eCollection 2022.

Authors

Mingchuang Zhu¹, Qingpeng Zeng², Tao Fan¹, Yuanyuan Lei², Feng Wang², Sufei Zheng², Xinfeng Wang², Hui Zeng², Fengwei Tan², Nan Sun², Qi Xue², Jie He^{1

2}

Affiliations

¹ Department of Oncology, Renmin Hospital of Wuhan University, Wuhan, China.
² National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2022.783495.].

Keywords: early-stage lung adenocarcinoma (LUAD); immune checkpoints(ICP); lipid metabolism; recurrence; signature.

Copyright © 2022 Zhu, Zeng, Fan, Lei, Wang, Zheng, Wang, Zeng, Tan, Sun, Xue and He.

Publication types

Published Erratum